BANGALORE, India , Nov. 15, 2024 /PRNewswire/ -- The Global Hard Empty Capsule Market was valued at USD 2851.5 Million in 2023 and is anticipated to reach USD 3921.4 Million by 2030, witnessing a CAGR ...
Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...